Incidence of PN by grade and resulting discontinuation/dose reduction in patients receiving BV + AVD for newly diagnosed Hodgkin lymphoma (n = 153). Dark blue sections represent patients in each group for whom the BV component of treatment was discontinued as a result of neuropathy (median number of treatments omitted = 4) and dark green represent those for whom BV dose was reduced.